Anna Parsons FNP’s Post

Absolutely unconscionable that this is where we are at in our response. Enough journal article writing. We have long known of CNS reservoir persistence, including the work of Dr. Daniel Chertow in December, 2021. He observed persistence in the basal ganglia, to which the substantia nigra belongs. So, this comes as no surprise. We have long known that every cell type that constitutes the CNS reservoir of those living with HIV is productively infected by SARS-Cov-2: perivascular macrophages, the choroid plexus, pericytes, astrocytes, and microglia. The CNS reservoir is expanding on a daily basis relying upon the same mechanism observed in HIV, the Tunneling Nanotube, implicated by Ana Pepe in 2022. Our intellectual capital’s immune competence and cognition is being destroyed on a daily basis, for which there will be no recovery. Stop writing. Take action. Disgusting and depraved.

🚨 Groundbreaking Study Alert! 🚨 Researchers from Weill Cornell Medicine & partners have made a pivotal discovery about COVID-19’s impact on the brain! 🧠 Key Insights: 🦠 SARS-CoV-2 infects dopamine neurons, potentially causing long COVID symptoms. 🔬 About 5% of dopamine neurons are affected, leading to dysfunction and inflammation. 💡 Study reveals specific drugs that could protect the brain from the virus. This research could revolutionize our approach to treating long COVID symptoms and protecting brain health. 🌟 Read the full study for a deep dive into these fascinating findings! 📚✨ #COVID19 #Neuroscience #BrainHealth #MedicalResearch

This is a really interesting read. TL:DR COVID-19 is able to infect dopamine neurons, which may be contributing to long COVID symptoms (such as brain fog and depression). The infected neurons go into a state where they don't grow or reproduce. It will be interesting to see if this causes long term damage that increases the chances of patients later developing neurodegenerative diseases connected to the dopamine pathway, such as Parkinson's Disease, the rates of which are already on the rise due to other factors.

Neuroservices-Alliance supports #RareDiseaseDay! In 2024, more than 300 million people worldwide live with a rare disease. Almost half of these diseases are neurological, and 90% of rare childhood disorders have major neurological effects. Neuroservices-Alliance is committed to identifying partners interested in accelerating the success rate of preclinical research in this challenging space by pursuing electrophysiology in novel models, e.g., iPSC-derived neurons and transgenic models. If you are currently developing molecule targeting rare neurological disorders, reach out to contact@neuroservices-alliance.com to discuss how we can help advance your research. #rarediseaseday2024 #CNSresearch #electrophysiology #drugdiscovery #CNSdrugdiscovery

🚀 New publication: 🚀 Our study explores how preoperative imaging can be used to predict non-motor outcomes of Deep Brain Stimulation (STN-DBS) for advanced Parkinson's Disease. 🧠💡 Using diffusion MRI, we identified key brain areas where microstructural properties predict postoperative non-motor burden. 📈🔍 Key findings: Improvement linked to intact microstructure in the right insular cortex, right putamen, right cingulum, & bilateral corticospinal tract. Specific brain regions identified which are associated with changes in sleep, attention/memory, urinary symptoms, & apathy. This research could enhance preoperative patient counselling, helping to predict who may benefit most from STN-DBS. 🌟🧠 Read more here: https://lnkd.in/dzHxtcDs A big thanks to the whole team for the great effort and the participants for their invaluable contribution!

I have friends and family dealing with Traumatic Brain Injuries, so intrigued by the recent research and developments to improve recovery and the outcomes of these events. For Traumatic Brain Injuries, a recent study found that "one of the more effective ways of preventing the devastating effects of traumatic brain injury might be to fix TDP-43 (biomarker) and prevent its mislocalization early after injury." #TBI #neurologyresearch

How 40Hz sensory gamma rhythm stimulation clears amyloid in Alzheimer's mice . Stimulating a key brain rhythm with light and sound increases peptide release from interneurons, driving clearance of Alzheimer's protein via the brain's glymphatic system, new study suggests. #ScienceDailynews #InnovativeResearch #NextGenScience #ExploringFrontiers

TMS treatments are long proven and accepted for common disorders like depression. However, to get the most impact, we need to understand how to personalize generic treatments to the individual. The right EEG hardware is key to determine individualized baselines and modify treatment protocols. Learn more and get yours at sales@cgxsystems.com! EEG Individual Alpha Frequencies May Predict Clinical Outcome in TMS Treatment - Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation https://lnkd.in/eGqK7RdW

In this article, Daniel Georges Olle Olle, Julien Zoobo Bisse & Ghislain Abessolo Alo’o explore the abilities of two approaches to diagnose Alzheimer’s disease with MRI. https://lnkd.in/eKp-jJvu